Hhlr Advisors, Ltd. Moderna, Inc. Transaction History

Hhlr Advisors, Ltd.

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	BUY	$118.38 - $210.04 $1.78 Million - $3.15 Million	15,000 New	15,000 $2.69 Million
Q4 2019 Feb 14, 2020	SELL	$13.93 - $21.28 $13.6 Million - $20.8 Million	-978,434 Closed	0 $0
Q3 2019 Nov 14, 2019	BUY	$12.26 - $18.07 $12 Million - $17.7 Million	978,434 New	978,434 $15.6 Million

954

241M

10.6M

18.7M

Ticker MRNA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 391,200,000
Market Cap $14.4B
Description
Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...

Get notified when there are updates to the investment portfolio of Hhlr Advisors, Ltd., based on Form 13F filings with the SEC.

Stay updated on Hhlr Advisors, Ltd. with notifications on news.